Shanghai ZJ Bio-Tech Co., Ltd. (688317.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 16.26

From 52W high−10.29%

Volume2.07M

Market capCNY 3.26B

P/E (TTM)−95.0x

P/S (TTM)26.5x

Div yield—

Key dataSep 18, 2026

Open

CNY 16.26

From 52W high

−10.29%

Volume

2.07M

Market cap

CNY 3.26B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

56.1x

P/E (TTM)

−95.0x

RSI (14)

46.1

MomentumView details →

1D Return

−2.99%

YTD Return

—

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

−95.0x

EV/EBITDA

56.1x

EV/Sales

8.4x

P/S (TTM)

26.5x

P/B (TTM)

1.0x

ProfitabilityView details →

Gross Margin

65.11%

Net Margin

−37.08%

EBITDA Margin

14.98%

ROE (TTM)

−1.33%

ROA (TTM)

−1.18%

Asset Turnover

0.03x

GrowthView details →

Revenue YoY

−25.98%

EPS YoY

+71.85%

FCF YoY

−28.04%

Revenue CAGR 3Y

−62.28%

EPS CAGR 3Y

+71.64%

EBITDA YoY

—

MomentumView details →

1D Return

−2.99%

YTD Return

—

1Y Return

—

RSI (14)

46.1

vs 50D SMA

−1.12%

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

0.09x

Current Ratio

25.19x

Quick Ratio

24.76x

Div Yield

—

Div Rate

—

Div Growth 1Y

−90.83%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

118.10M

Net Income (TTM)

−43.79M

Op. CF (TTM)

61.19M

Latest newsMore news →

ZhiJiang Bio announced its 2026 first-half results, reporting a net loss of 40.5894 million yuan, compared with a loss of 9.851 million yuan in the same period of 2025.24d ago

Zhi Jiang Bio announced that its monkeypox virus nucleic acid detection kit (fluorescent PCR method) obtained a Class III medical device registration certificate from China's NMPA, valid from August 17, 2026 to August 16, 2031, allowing use in China and other countries recognizing NMPA.32d ago

Similar companies

Laekna, Inc.02105.HK 申联生物688098.SH Arcus Biosciences, Inc.RCUS Veracyte, Inc.VCYT Dyne Therapeutics, Inc.DYN Arcutis Biotherapeutics, Inc.ARQT Find similar companies →

Latest newsMore news →

ZhiJiang Bio announced its 2026 first-half results, reporting a net loss of 40.5894 million yuan, compared with a loss of 9.851 million yuan in the same period of 2025.24d ago Zhi Jiang Bio announced that its monkeypox virus nucleic acid detection kit (fluorescent PCR method) obtained a Class III medical device registration certificate from China's NMPA, valid from August 17, 2026 to August 16, 2031, allowing use in China and other countries recognizing NMPA.32d ago